|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 49/10 | |
| A61K 49/18 | |||
| A61K 9/51 | |||
| A61K 31/555 |
| (11) | Number of the document | 2993983 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14794410.2 |
| Date of filing the European patent application | 2014-05-08 | |
| (97) | Date of publication of the European application | 2016-03-16 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/037234 |
| Date | 2014-05-08 |
| (87) | Number | WO 2014/182868 |
| Date | 2014-11-13 |
| (30) | Number | Date | Country code |
| 201361821106 P | 2013-05-08 | US |
| (72) |
MEDINA-KAUWE, Lali, K., US
|
| (73) |
Cedars-Sinai Medical Center,
8700 Beverly Boulevard, Los Angeles, CA 90048,
US
|
| (54) | TARGETING CORROLES FOR TUMOR TOXICITY AND MRI |
| TARGETING CORROLES FOR TUMOR TOXICITY AND MRI |